Company / Operating Cash Flow per Share
Atea Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.46
FY2022
5-year range
-$1.46 / -$0.16
FY2020-FY2022
Trend
-835.5%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -835% YoY in FY2022, a notable deviation from the 2-year average annual change of -378%.
Based on SEC 10-K filings.
-1.46 in FY2022.
Declined from $-0.78 to $-1.46 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating cash flow per share decreased 835.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.46 | -835.5% |
| FY2021 | -$0.16 | +80.1% |
| FY2020 | -$0.78 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026